The human repair gene ERCC6-B presumed DNA (or RNA) hellcase-has recently been found to function specifically In preferential nucleotlde excision repair (NER). This NER subpathway Is primarily directed towards repair of (the transcribed strand of) active genes. Mutations In the ERCC6 gene are responsible for the human hereditary repair disorder Cockayne's syndrome complementation group B, the most common form of the disease. In this report, the genomic organization and expression of this gene are described. It consists of at least 21 exons, together with the promoter covering a region of 82-90 kb on the genome. Postulated functional domains deduced from the predicted amino acid sequence, Including 7 distinct hellcase signatures, are-with one exception-encoded on separate exons. Consensus splice donor and acceptor sequences are present at all exon borders with the exception of the unusual splice donor at the end of exon VII. The 'invariable' GT dinucleotlde In the consensus (C,A)AG/GTPuAGT is replaced by the exceptional GC. Based on 42 GC splice donor sequences identified by an extensive literature search we found a statistically highly significant better 'overall' match of the surrounding nucleotides to the consensus sequence compared to normal GT-shtes. This confirms and extends the observation made recently by Jackson (Nucl. Adds Res. ,19, 3795 -3798 (1991)) derived from analysis of 26 cases. Analysis of ERCC6 cDNA clones revealed the occurrence of alternative polyadenylatlon, resulting In the (differential) expression of two mRNA molecules (which are barely detectable on Northern blots) of 5 and 7 kb In length.
INTRODUCTION
Nucleotide excision repair (NER) is one of the major DNA repair systems functioning in mammalian cells (1) . It is able to remove a broad variety of DNA lesions, such as UV-induced pyrimidine dimers and (6-4) photoproducts, as well as bulky chemical lesions and DNA cross links. After induction of DNA damage, the NER machinery appears to be directed first primarily towards the transcribed regions in the genome. This enables the cells to rapidly resume the vital process of transcription, that otherwise would remain blocked by lesions in the DNA template (2) . This preferential repair of active genes is even specific for the transcribed strand (3) . Removal of lesions from the nontranscribed strand, as well as from inactive chromatin proceeds more slowly and appears to be incomplete for several lesions (4 for a recent review). In human cells, repair of the nontranscribed strand is more rapid than that of inactive genes (5).
In the rare hereditary disorders xeroderma pigmentosum (XP) and Cockayne's syndrome (CS), deficiencies in NER are thought to underlie the clinical symptoms. XP patients are clinically characterized by severe sun(UV)sensitivity of the skin, pigmentation abnormalities, a highly elevated risk for developing skin tumors, and often neurological degeneration (6) . Cell fusion experiments with cells from these patients have distinguished 7 NER-deficient complementation groups (eg; XP-A to XP-G) (7, 8) . The biochemical basis for the XP NER-defect probably resides in undefined early steps of the pathway preceding incision and repair (9) . For XP-C cells the defect appears to be specific for repair of inactive chromatin; these cells have retained the ability to remove damage from the transcribed strand of active genes (10, 11, 12) . CS patients have, in sharp contrast to XP, no pigmentation abnormalities and no elevated risk for skin tumor formation. They are clinically characterised by skeletal and retinal abnormalities, growth retardation, progressive neurological degeneration, and a sunsensitive skin (13, 14 for reviews). Like XP, CS is heterogeneous: 2 eg have been identified (CS-A, -B) (15, 16) . The molecular defect in CS-A and -B was shown to affect preferential repair of active genes only, whereas repair of the inactive chromatin regions proceeds normally (17) . A third complementation group was defined (CS-C), containing one patient that exhibited a combination of characteristics of XP and CS. This patient is also classified as XP-B (16, 18) . Several patients exhibiting this combined XP/CS phenotype are reported; one of these has been assigned to XP group D (8) .
Another class of mammalian NER-deficient mutants consists of laboratory-induced, UV-sensitive, rodent (mainly Chinese hamster) mutant cell lines. Among these, at least 10 eg have been defined (19, 20, 21, 22) . A number of rodent mutants have been succesfully used for isolation of human genes capable of correcting the rodent repair deficiency (23 for a recent review). Subsequent introduction of these genes into XP and CS cells has demonstrated an overlap between the hamster and human eg: rodent eg 2 and 3, corrected by ERCC2 and -3, are the rodent equivalents of XP-D and XP-B, respectively (24, 25) . Recently, we have isolated the human repair gene ERCC6 by virtue of its ability to correct the UV-sensitivity of the Chinese hamster ovary (CHO) mutant cell line UV61, eg 6 (26) . The gene encodes a protein of 1493 amino acids; the predicted amino acid sequence suggests that the ERCC6 gene product is a nuclear DNA helicase. Mutations in the ERCC6 gene appear to be responsible for the repair deficiency of CS-B cells, implying that the ERCC6 gene product is specifically involved in the process of preferential repair (27) . This paper describes the genomic architecture and expression of the ERCC6 gene.
MATERIALS AND METHODS

General procedures
Purification of nucleic acids, restriction enzyme digests, gel electrophoresis, DNA ligarion, synthesis of radiolabeled probes using random oligonucleotide primers, the polymerase chain reaction (per), sequence analysis (dideoxy-mediated chaintermination), and filter hybridization were performed according to established procedures (28) .
Construction of the cDNA plasmid
Construction of the (almost) full length ERCC6 cDNA was as described (27) . The cDNA insert was subcloned into both the vector pTZ19R (Pharmacia) yielding pTZE6total, and the mammalian expression vector pSLM, a derivative of pSVL (Pharmacia; Van Duin, unpublished results). In the mammalian expression vector the ERCC6 cDNA is under the control of the SV40 late promoter, whereas in pTZE6total the cDNA is not preceded by a eukaryotic promoter.
Cell culture, transfection, and selection UV-sensitive CHO cell line UV61 and wt CHO cell line AA8 were grown in 1:1 FlO-Dulbecco minimal essential medium supplemented with antibiotics and 8% fetal calf serum. The ERCC6 cDNA construct pTZE6total (3 fig) was cotransfected with 2 iig pSV2neo and 20 /xg lambda phage 6B (see Fig.l ) to UV61 cells. In order to release the lambda arms and plasmid vector from the inserts prior to transfection, both pTZE6total and lambda phage 6B were digested with Sal I; an enzyme which does not cut within the insert. Transfection and selection were performed as described before (27) .
Identification of intron-exon borders
All genomic fragments hybridizing to the ERCC6 cDNA were subcloned in pTZ19R (Pharmacia) or pBluescript II KS (Stratagene), and sequenced with £7?CC<5-specific primers. All sequence reactions were performed on double-stranded templates by the dideoxy chain termination method, using T7 DNA polymerase (Pharmacia). Intron length was determined either by restriction enzyme digestions and subsequent Southern blot analysis or by per with exon-specific primers on subcloned genomic fragments.
Northern blot analysis RNA samples were separated on an agarose gel and transfered to a nylon membrane (Zeta probe from Bio-Rad) as described by Fourney et al. (29) . The filters were hybridized at 65°C, in 3 xSSC, lOxDenhardt's reagent, 0.1 % SDS, 90 /tg/ml dextran sulfate, and 50 /ig/ml denatured salm sperm DNA. Filters were washed 2 times (10 min.) in 3xSSC, 0.1% SDS and once (10 min.) in lxSSC, 0.1% SDS, at 65°C.
Synthesis of strand-specific probes
Strand-specific probes were synthesized according to the method described by Espelund et al. (30) , with several modifications. The template was generated by per, with one normal and one biotinylated primer. The biotinylated product was then bound to streptavidin-coated magnetic beads (Dynabeads M-280, Dynal) through a 30 min. incubation at 37°C in 5XSSPE (20XSSPE: 3.6M NaCl, 200mM NaH 2 PO 4 pH7.4, 20mM EDTA pH7.4). The beads were washed 4x with a solution containing 0.17% (w/v) Triton X-100, 100 mM NaCl, 10 mM Tris.HCl pH7.5, and 1 mM EDTA; subsequently the non-biotinylated strand was removed by 2 cycles (7 min. each) of denaturation in 125 mM NaOH, 100 mM NaCl. After washing twice with 100 mM Tris.HCl pH7.6, 150 mM NaCl, the biotinylated strand is radioactively labeled via primer extension. The beads were washed 3 X, and the DNA was denatured by two incubations (7 min. each) in 125 mM NaOH, 100 mM NaCl. The supernatant was neutralized with an equal volume of 1M Tris.HCl (pH7.5), and used in hybridizations.
RESULTS
Architecture of the ERCC6 gene
ERCC6 promoter region. The ERCC6 gene was isolated from a lambda EMBL3 library originating from a repair-proficient secondary UV61 transformant. The genomic region coinherited by independent, repair-proficient primary and secondary UV61 transformants, as judged by Southern blot analysis, was approximately 100 kb, and consequently separated over several lambda clones (26) . A physical map of this region is shown in Fig. 1 . The size of the ERCC6 locus was determined by hybridization of an (almost) full length, functional cDNA of 4.7 kb, encoding at least the total open reading frame and the 3' end (of the shortest mRNA, see below), to the different lambda clones. The cDNA, previously localized on chromosome 10qll-21 (31), was shown to encompass 82 kb at the genome level ( Fig. 1) and to reside on a 430 kb Not I fragment (data not shown). One of the Not I sites is part of a CpG-island present in the 5' region of the ERCC6 gene (Fig. 1) . To pinpoint the region containing the promoter and the 5' untranslated end of the mRNA (part of which might be lacking in the cDNA), a promoterless cDNA construct (pTZE6total, see Materials and Methods) was cotransfected with lambda clone 6B, containing the first 4 exons present in the cDNA, and approximately 8 kb more upstream sequences (Fig. 1) . To be expressed, the promoterless cDNA should recombine within the cell with the cotransfected lambda phage, thus producing a 'mini gene'. After transfection of the two DN As together UV-resistant clones were obtained, with an efficiency that was = 10X lower than after transfection of a eukaryotic expression vector carrying the ERCC6 cDNA behind the SV40 late promoter. The UV-sensitivity was corrected to a level within wt range (Fig. 2) , as determined by survival experiments with pooled clones. To rule out the possibility that the UV-resistant transformants obtained in the cotransfection experiments were caused by fortuitous integration behind an endogenous promoter, instead of reconstitution of a functional gene by recombination between the 5' ERCC6 gene part with the rest of the cDNA, we also transfected the cDNA without a functional promoter at its 5' end. In this experiment, in which the cDNA was placed in the inverted orientation in vector pSLM, no UV-resistant clones were obtained. These findings strongly suggest that a functional gene has indeed been generated via homologous recombination (between the lambda and cDNA clones) within the cell. The promoter should then be situated within the ±8 kb genomic region 5' of the first exon present in the cDNA clone. The ERCC6 locus thus covers a region of 82-90 kb.
Intron exon structure. Appropriate fragments were subcloned into plasmid vectors in order to determine intron-exon borders. Sequence analysis demonstrated the ERCC6 cDNA to be dispersed over 21 exons (Fig. 1) . The CpG-island present in the 5' region of the ERCC6 gene is situated within the first intron of ERCC6 (Fig. 1) . The first exon present in the cDNA does not contain any coding information, analogous to the first exon in another repair gene, ERCC1 (32). Since we have not determined the transcriptional start site, we cannot exclude the presence of an additional exon more 5' on the genome, which is absent in the cDNA. The presence of a CpG-island in-the first intron, however, argues against the existence of an additional 5' exon located far upstream. The tentatively identified functional domains are-with the exception of helicase signature VIencoded by separate exons (Fig. 3 and 4) . As shown in Fig. 3 , all sequences around intron-exon and exon-intron borders are consistent with the consensus splice acceptor and donor signals (33) , with the exception of the splice donor of the intron VH. The canonical GT dinucleotide at the beginning of the intron is replaced by GC (see below). In all introns, the weakly defined branchpoint sequence (PyNPyTPuAPy) could be tentatively identified at the appropriate distance (10-50 nt) from the splice acceptor site (underlined in Fig. 3) (33, 34) . One alternatively spliced cDNA molecule has been isolated, in which exon VIE was found to be skipped. The sizes of internal exons range from 79 to 745 nt. Three of the internal exons (exon n, V, and XVm) have an exceptional size: (33) . The nucleotides at the borders of each exon are numbered as reported previously (27) . The size of introns and exons are given between parenthesis (in bp, if not indicated otherwise). The postulated functional domains (27) encoded by the different exons are indicated: acidic, stretch of acidic aa; NLS/CKII, putative nuclear location signal followed by a postulated casein Irinase D phosphorylation site; heli I to VI, helkase domains I to VI; NTB, putative nucleotide binding fold.
436, 745 and 708 nt, respectively; the average exon length for vertebrate internal exons being 137 nt (35) . Intron lengths range from 85 to 19,000 nt; the average size of vertebrate introns being 1,127 nt (35) .
ERCC6 gene expression and alternative polyadenylation Northern blot analysis of human poly(A)
+ RNA demonstrated the presence of two ERCC6 transcripts of approximately 5 and 7 kb in length, both expressed at a very low level (Fig. 5) . To examine the structure of the long ERCC6 mRNA, various cDNA libraries were screened for the presence of clones with extra sequences not found in the 4.7 kb cDNA. One of the isolated (partial) cDNAs had a 3' untranslated region extending 2 kb more 3' as the mentioned 4.7 kb construct. It contained a poly(A)tail, preceded by the common polyadenylation signal AATAAA (36, 37) . The total length of the isolated cDNA then becomes ±6.7 kb, probably reflecting the longest mRNA. Sequence analysis and restriction enzyme digests showed the 3' untranslated region to be colinear with the genome. This suggests the 2 mRNA products to be the result of alternative polyadenylation (Fig. 1) . Analysis of mouse tissues revealed the presence of elevated (though still very low) levels of ERCC6 mRNA in brain and testis; in most other tissues transcription was below detection level (Fig. 5) . Also in mouse two transcripts are identified, suggesting that the alternative polyadenylation is conserved. Remarkably, the larger transcript is the most abundant in mouse brain, whereas in testis the smaller mRNA is the more frequently occurring one (Fig. 5) .
In human RNA, a third transcript of 3.5 kb is detected, with probes in the 5' 1.7 kb of the gene. A probe from nt 1662 to 3746 did not detect this short transcript. Both a probe covering the first 350 bp of the cDNA (exon I and part of exon II) and one spanning nt 1020 to 1667 (part of exon V, exon VI and 60 nt of exon VII) recognize this short transcript, suggesting that at least sequences from exon I or n as well as exon V or VI (and maybe the 60 nt of exon VII) should be present. The transcript is detected in both total and poly A + RNA. Hybridizations with strand-specific probes, as shown in Fig. 5 , have excluded the possibility of an overlapping antisense gene: the transcript appears to be produced from the same strand as the two longer ERCC6 mRNAs. Since we have been unable to identify ERCC6 transcripts in mouse tissues with a 5' probe, it is unclear whether the 3.5 kb transcript is conserved through evolution.
DISCUSSION
The ERCC6 gene product, which is predicted to be a nuclear DNA helicase, has recendy been shown to be involved in the human DNA repair disorder Cockayne's syndrome (27) . In this paper, the expression and structural organization of the ERCC6 gene are reported.
Two lowly expressed ERCC6 mRNA molecules of 5 and 7 kb have been identified by Northern blot analysis of human poly(A) + RNA (Fig. 5) . Two types of cDNAs have been isolated, varying in their 3' end by differential polyadenylation. The second polyadenylation site, accompanied by die common polyadenylation signal AATAAA, is present 2 kb downstream of the first one that contains the less preferred signal ATTAAA (36, 37) . Alternative polyadenylation occurs in many genes, including another human NER gene ERCC1 (32) . It is unclear though, whether diis has any regulatory function. In this respect, it is interesting to note that often the alternative polyadenylation is evolutionarily conserved, as it is-presumably-for ERCC6. We noted differential expression of the two transcripts in mouse brain and testis (Fig. 5) . It is unknown whether the elevated expression of the longest ERCC6 mRNA in brain is related to the (severe) progressive neurological degeneration in CS patients. Also the function of the (human) 3.5 kb transcript encompassing only the 5' region of the ERCC6 cDNA is unresolved. Hybridization with strand-specific probes ruled out the possibility of an overlapping antisense gene. An overlapping gene in sense direction seems unlikely, since it should men have (parts) of at least 2 exons (exons I or II and V, VI or VH) in common widi the ERCC6 gene. A third possibility is diat the 3.5 kb transcript is the result of a (strong) transcriptional stop due to the presence of an attenuation site. The attenuation site should then be within or 3' of exon V, which is approximately 15 kb (or more) from the transcriptional start site. Normally, attenuation takes place within a few hundred bp from the transcription initiation site, although there is one example of a termination site » 2 kb from the start (c-myb) (38) . If, for the ERCC6 gene, me stop site is 3' of exon V, it could be within the 19 kb long intron V. Crosshybridization of unique human sequences from this intron to rodent DNA suggested the presence of 2 conserved regions within intron XIX (unpublished observations). It is possible tiiat a second gene is located within this large intron, with transcription termination sequences that can be recognized by RNA polymerase complexes transcribing the ERCC6 gene. Spacing of this prematurely terminated transcript might result in the observed 3.5 kb mRNA. A more conclusive statement concerning the role of this short (truncated) ERCC6 transcript should, however, await further research, particularly by the isolation of corresponding cDNAs. So far, no such cDNAs have been isolated, despite the screening of several cDNA libraries.
The ERCC6 locus is 82 -90 kb in length, and harbors at least 21 exons. The presence of a CpG-island within intron I (Fig. 1) suggests that there is no unidentified exon more 5' (containing extra 5' untranslated sequences not present in the cDNA), although we cannot completely exclude this possibility. It is interesting to note that also ERCC2 and ERCC3 have CpG-islands within the first intron (39, 40) . The putatively identified functional domains in the ERCC6 cDNA sequence are-with one exception-dispersed over separate exons. It has been proposed that modern eukaryotic genes may have been assembled from a limited number of ancestral exons encoding separate functional domains (41) . Within ERCC6, only helicase domain VI is split by intron XV (see Fig. 3 and 4) . Interruption of helicase domains by introns has been noted before: yeast RNA helicase p68 contains one intron in domain V (42), which is positionally conserved (between human, Saccharomyces cerevisiae, and Schizosaccharomyces pombe); within the ERCC3 gene (encoding a putative DNA helicase) both domain I and V are interrupted (40) .
In one of the isolated ERCC6 cDNAs exon VUI was found to be skipped. Although we cannot completely exclude the possibility that a mRNA molecule without exon Vm has any functional potential, it seems unlikely. The exon skipping results in a frameshift; consequently, the mRNA only encodes a very short protein. Presumably, this unconventionally spliced mRNA is the result of an erroneous splice event, rather than the product of a mechanism that creates an alternative, functional ERCC6 protein.
All splice sites, with the exception of the splice donor at the 3' end of exon VH, are in reasonable accordance with the consensus sequences (Py) n CAG/G and (C,A)AG/GTPuAGT for donor and acceptor, respectively (33) . In the splice donor of intron VII, the 'invariable' GT dinucleotide is replaced by GC. 'GC' instead of 'GT' splice donors are very rare. Recently, Jackson (43) compared 26 'GC' splice donors from the literature, and noted that as a group they have a better 'overall' match to the (C/A)AG/GTAAGT consensus than the regular 'GT' donors. To assess the validity of this finding and to make conclusions statistically more significant, we have screened various data bases for additional 'GC' splice donors, and extended the list to a total of 42 ( Table I ). The comparison presented in Table II clearly confirms and strengthens the observation made by Jackson: 'GC' splice sequences display as a whole at all (remaining) positions a substantially higher level of complementarity to the Ul snRNA than the group of 'GT' donors. Particularly the G residue at position +5 seems invariant, whereas the 'G' at -1 is almost invariant. Most sites have 6-8 bases matching Ul snRNA (6 sites have 8 matches, 21 sites have 7 matches, 12 sites have 6 matches, the remaining 3 sites only have 5 bases matching to Ul snRNA). Apparently, the mismatch in base pairing with Ul snRNA caused by the GT to GC alteration needs to be compensated by a better match of the rest of the sequence, in order to permit the assembly of a functional spliceosome.
Three of the internal ERCC6 exons (exons widiout either a cap site or a polyadenylation signal) are exceptionally large: 436, 708, and 745 nt (exons II, XVHJ, and V respectively). Out of 1305 internal vertebrate exons examined by Hawkins, only 7 exceed 550 nt; the average length being 137 nt (35) . A conceivable explanation for the scarcity of large internal exons, as proposed by Robberson and colleagues (44) is based on the idea that, in order to stably form a spliceosome, factors bound at the 5' and 3' border of an exon need to 'communicate'. The interaction between the different factors might become less stable if the exon length exceeds a certain limit. In vitro splicing experiments demonstrated splicing of an intron followed by a large exon (> 300 nt) to be less efficient than splicing of the same intron preceding a small exon (<300 nt) (44) . Whether this is true in vivo too, is unknown. If so, it might (partly) explain the low expression level of the ERCC6 gene.
